Delivery Order SPE2DB20D2014-SPE2DB25FC13C
Award Date
6/5/25
Potential Completion Date
6/6/25
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,228.56 firm fixed-price delivery order is for the supply of 4567644031 CEFAZOLIN 2 G/50 ML-DEXTROSES, a medical product. The contract has an ultimate completion date of March 21, 2025 and was awarded on March 20, 2025. It is not associated with a set-aside program. Amerisourcebergen holds a significant...
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,393.30 firm fixed-price delivery order is for the supply of CEFAZOLIN 2 GM VIALS, a type of antibiotic medication. The contract has a period of performance through June 12, 2025 and is not designated as a set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,959.52 firm-fixed-price delivery order is for the supply of CEFAZOLIN 1 G/50 ML-DEXTROSES, a medical product, with an ultimate completion date of October 30, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is for a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,162.80, is for the delivery of 4566066569 - CEFAZOLIN 2 G/50 ML-DEXTROSES, a common antibiotic medication. The contract has a firm fixed price pricing type and an ultimate completion date of October 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $3,140.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies,...
The U.S. Defense Logistics Agency (DLA) has awarded a firm-fixed-price delivery order contract worth $2,374.92 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 4564782841 CEFAZOLIN 2 G/50 ML-DEXTROSES, a pharmaceutical product, with a period of performance through June 4, 2024. This delivery order is made under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,212.28 Firm Fixed Price Delivery Order contract is for the supply of CEFAZOLIN 2 G/50 ML-DEXTROSES, a medical product used in healthcare settings. The contract has an ultimate completion date of January 16, 2025 and was awarded on January 15, 2025. It is not designated as a set-aside contract....
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the provision of CEFAZOLIN 2 G/50 ML-DEXTROSES medical supplies. The contract has an award value of $1,032.45 and a completion date of July 29, 2024. It is a delivery order contract under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,167.92, is for the delivery of 4564171961 CEFAZOLIN 2 G/50 ML-DEXTROSES, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of April 5, 2024. This award is not associated with a set-aside program. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,032.45 firm-fixed-price delivery order is for the supply of CEFAZOLIN 2 G/50 ML-DEXTROSES, a critical medical commodity. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary...